In the BioHarmony Drug Report Database

"Preview" Icon

Ofloxacin

Floxin, Floxin Otic, Ocuflox, Quinsair (ofloxacin) is a small molecule pharmaceutical. Ofloxacin was first approved as Floxin on 1990-12-28. It is used to treat bacterial conjunctivitis, bacterial infections, bacterial skin diseases, bronchitis, and chlamydia infections amongst others in the USA. It has been approved in Europe to treat cystic fibrosis and respiratory tract infections.

 

Trade Name

 

Quinsair
 

Common Name

 

ofloxacin
 

ChEMBL ID

 

CHEMBL4
 

Indication

 

bacterial conjunctivitis, bacterial infections, bacterial skin diseases, bronchitis, chlamydia infections, corneal ulcer, cystic fibrosis, cystitis, epididymitis, escherichia coli infections, gonorrhea, haemophilus infections, helicobacter infections, klebsiella infections, otitis externa, prostatitis, proteus infections, protozoan infections, pulmonary tuberculosis, respiratory tract infections, salmonella infections, soft tissue infections, staphylococcal infections, suppurative otitis media, urinary tract infections
 

Drug Class

 

Antibacterials (quinolone derivatives)

Image (chem structure or protein)

Ofloxacin structure rendering